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Akt   protein kinase B 
ATP   adenosine triphosphate 
ATR   Ataxia telangiectasia and Rad3-related protein 
ATX1   Arabidopsis homolog of trithorax 
BAF   BRM- or BRG-associated factors  
BASP1  brain acid soluble protein 1 
BRG1  Brahma-related gene 1 
BRM   Brahma gene 
DAG   diacylglycerol 
DFC   dense fibrillar component 
DNA   deoxyribonucleic acid 
EEA1   early endosome antigen 1 
FC   fibrillar centre 
FYVE   Fab1/YOTB/Vac1/EEA domain 
GC   granular component 
GFP   green fluorescent protein 
Grp1   general receptor for phosphoinostides 1 
H1   histone H1 
H3   histone H3 
H3K4meX  X-methylated lysine 4 at histone H3 
H3K9meX  X-methylated lysine 9 at histone H3 
HDAC1  histone deacetylase 1 
hnRNP U  heterogeneous nuclear ribonucleoprotein U 
Hrs   hepatocyte growth factor-regulated tyrosine kinase substrate 
IGCs   interchromatin granular clusters 
ING2   inhibitor of growth family member 2 
IP3   inositol 1,4,5-trisphosphate 
IPMK   inositol multiphosphate kinase 
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LSD1   lysine-specific histone demethylase 1 
MIGs   mitotic interchromatin granules 
NLIs   nuclear lipid islets 
NM1   nuclear myosin 1 
NORs  nucleolar organising regions 
NuMa  nuclear mitotic apparatus protein 
NXF1   nuclear RNA export factor 1 
OSH1  oxysterol-binding protein homolog 1 
PA   phosphatidic acid 
PBR   polybasic region 
PH   pleckstrin homology 
PHD   plant homeodomain 
PHF8   PHD finger protein 8 
PI   phosphatidylinositol 
PI(3)P  phosphatidylinositol 3-phosphate 
PI(3,4)P2  phosphatidylinositol 3,4-bisphosphate 
PI(3,4,5)P3  phosphatidylinositol 3,4,5-trisphosphate 
PI(3,5)P2  phosphatidylinositol 3,5-bisphosphate 
PI(4)P  phosphatidylinositol 4-phosphate 
PI(4,5)P2  phosphatidylinositol 4,5-bisphosphate 
PI(5)P  phosphatidylinositol 5-phosphate 
PI3KC2α  phosphatidylinositol 3-kinase type IIα 
PI3KC2β  phosphatidylinositol 3-kinase type IIβ 
PI4Kα  phosphatidylinositol 4-kinase α 
PI4Kβ  phosphatidylinositol 4-kinase β 
PIP4KIIα  phosphatidylinositol 5-phosphate 4-kinase type IIα 
PIP4KIIβ  phosphatidylinositol 5-phosphate 4-kinase type IIβ 
PIP4KIIγ  phosphatidylinositol 5-phosphate 4-kinase type IIγ 
PIP5KIα  phosphatidylinositol 4-phosphate 5-kinase type Iα 
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PIP5KIγ_i4  phosphatidylinositol 4-phosphate 5-kinase type Iγ_i4 
PIs   phosphoinositides 
PLC   phospholipase C 
PTEN  phosphatase and tensin homolog 
RING   really interesting new gene 
RNA   ribonucleic acid 
RNA pol I/II  RNA polymerase I/II 
SC-35  serine/arginine-rich splicing factor 2 
SF-1   steroidogenic factor 1 
SHIP-1  Src homology 2 domain-containing inositol 5-phoshpatase 1 
SHIP-2  Src homology 2 domain-containing inositol 5-phoshpatase 2 
Sin3A  paired amphipathic helix protein Sin3a 
Star-PAP  nuclear speckle targeted PIP5KIα regulated-poly(A) polymerase 
TAF3   TATA box binding protein (TBP)-associated factor 3 
TBP   TATA box binding protein 
TREX  transcription-export 
TTD   tandem tudor domain 
UBF   upstream binding factor 
UHRF1  ubiquitin-like PHD and RING finger domains-containing protein 1 
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Phosphoinositides (PIs) are glycerophospholipids with a negative charge. As 
components of cell membranes, PIs are involved in membrane and cytoskeletal 
dynamics, cell movement and signalling, and the modulation of ion channels and 
transporters. Apart from the cytoplasm, phosphoinositides also localise to the cell 
nucleus. PIs play a role in crucial nuclear processes, such as DNA transcription, 
pre-rRNA and pre-mRNA processing, cell differentiation, DNA damage response, or 
apoptosis. Phosphatidylinositol 4-phosphate (PI(4)P) and phosphatidylinositol 
4,5-bisphosphate (PI(4,5)P2) are the most abundant phosphoinositides in the cell. 
However, their exact localisation and function in the nucleus are largely unknown. 
Here, we describe their localisation at super-resolution level and their involvement in 
some nuclear processes. 
PI(4)P is present in nuclear lamina, nuclear speckles and nucleoli, and it forms 
small foci in nucleoplasm. The majority of nuclear PI(4)P localises to the nucleoplasm, 
whereas almost 16 % is present in nuclear speckles. On the other hand, the majority 
of nuclear PI(4,5)P2 localises to nuclear speckles, almost 30 % localises to 
nucleoplasm and the lesser portion to nucleoli. In the nucleoplasm, PI(4,5)P2 forms 
small foci called nuclear lipid islets (NLIs). Their core is rich in lipids and is surrounded 
by proteins, RNA and DNA. The NLIs’ periphery is associated with RNA polymerase 
II (RNA pol II) transcription machinery. In addition, nuclear myosin 1 (NM1) localises 
to the NLIs’ periphery. NM1 interacts with PI(4,5)P2 directly and this interaction is 
required for RNA pol II transcription. The levels of active RNA polymerase II 
transcription are dependent on the levels of PI(4,5)P2. Therefore, NLIs provide a 
structural platform promoting the formation of RNA pol II transcription factories. 
Mass spectrometry analysis of immunoprecipitated PI(4)P lipid-protein 
complexes revealed almost 100 nuclear proteins participating in essential nuclear 
processes such as pre-mRNA processing, transcription or nuclear transport indicating 
the role of PI(4)P as an important player in the cell nucleus. 
Furthermore, we show that lysine-specific histone demethylase 1 (LSD1) 
interacts with PI(4)P and PI(4,5)P2 directly. LSD1 demethylates H3K4me2 active 
histone mark and thus represses transcription. The binding of PI(4)P to LSD1 inhibits 
its activity, on the contrary, the binding of PI(4,5)P2 to LSD1 stimulates its activity in 
vitro. Phosphorylation of PI(4)P or dephosphorylation of PI(4,5)P2 might also have a 




 Fosfoinositidy jsou glycerofosfolipidy se záporným nábojem. Jako složky 
buněčných membrán se podílejí na membránové dynamice, buněčném pohybu, 
signalizaci a na modulaci iontových kanálů a membránových transportérů. Kromě 
cytoplazmy fosfoinositidy také lokalizují do buněčného jádra. Fosfoinositidy hrají roli v 
klíčových jaderných procesech, jako je transkripce DNA, zpracování pre-rRNA a pre-
mRNA, reakce na poškození DNA, diferenciace buněk nebo apoptóza. 
Fosfatidylinositol 4-fosfát (PI(4)P) a fosfatidylinositol 4,5-bisfosfát (PI(4,5)P2) jsou 
nejhojnějšími fosfoinositidy v buňce. Lokalizace a funkce obou fosfoinositidů 
v buněčnem jádře je do značné míry neznámá. V této práci popisujeme lokalizaci 
PI(4)P a PI(4,5)P2 na úrovni superrozlišení a jejich zapojení do jaderných procesů. 
 PI(4)P je přítomen v jaderné lamině, jaderných speckles, jádérkach a tvoří 
malá ohniska v nukleoplasmě. Většina jaderného PI(4)P se lokalizuje do 
nukleoplasmy, zatímco jenom 16% je přítomno v jaderných speckles. V případe 
PI(4,5)P2 je situace opačná, většina je lokalizována v jaderných speckles, 30 % je 
v nukleoplasmě a menšina v jadérkách. V nukleoplazmě tvoří PI(4,5)P2 malé ložiska 
nazývané nukleární lipidové ostrůvky (NLIs). Jádro NLIs je bohaté na lipidy a je 
obklopené proteiny, RNA a DNA. Periferie NLIs je spojena s transkripcí katalyzovanou 
RNA polymerázou II (RNA pol II). Jaderný myosin 1 (NM1) lokalizuje na periferii NLIs, 
kde interaguje s PI(4,5)P2. Tato interakce je nezbytná pro transkripci 
zprostředkovanou RNA pol II. Hladiny aktivní transkripce RNA pol II jsou závislé na 
hladinách PI(4,5)P2. NLIs poskytují strukturální platformu podporující tvorbu 
transkripčních továren RNA pol II. 
 Analýza hmotnostní spektrometrie imunoprecipitovaných PI(4)P lipidovo-
proteinových komplexů odhalila téměř 100 jaderných proteinů účastnících se 
podstatných jaderných procesů, jakými jsou zpracování pre-mRNA, transkripce nebo 
jaderný transport. Tyto výsledky poukazují na zásadní roli PI(4)P v podstatných 
jaderných procesech. 
 V této práci dále ukazujeme, že lysin-specifická histon demetyláza 1 (LSD1) 
interaguje přímo s PI(4)P a PI(4,5)P2. LSD1 odstraňuje metylovou skupinu z 
H3K4me2 a potlačuje tak transkripci genů. Vazba PI(4)P na LSD1 inhibuje aktivitu 
enzymu, avšak aktivita enzymu je stimulována interakcí s PI(4,5)P2 in vitro. 
Fosforylace PI(4)P nebo defosforylace PI(4,5)P2 představuje možnost rychlého 





Phosphoinositides (PIs) are glycerophospholipids with a negative charge. PIs are 
amphipathic molecules, they contain hydrophobic fatty acyl tail and hydrophilic inositol 
head. By phosphorylation and dephosphorylation of the inositol head at 3’, 4’, and 5’ 
positions, seven different PIs can be formed: three monophosphates - 
phosphatidylinositol 3-phosphate (PI(3)P), phosphatidylinositol 4-phosphate (PI(4)P), 
phosphatidylinositol 5-phosphate (PI(5)P); three bisphosphates - phosphatidylinositol 
3,4-bisphosphate (PI(3,4)P2), phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and one trisphosphate - 
phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3; Figure 1). Their interconversion 
is tightly regulated by related kinases and phosphatases which phosphorylate or 
dephosphorylate the inositol ring at specific positions. Even though PIs form only a 
small portion of overall lipid content in the cell, they participate in various signalling 
pathways as important signalling molecules (reviewed in [1]).  
 
Figure 1: Schematic depiction of phosphoinositide species. Phosphatidylinositol (left) 
is composed of hydrophobic fatty acid tail and hydrophilic inositol head, which can be 
phosphorylated at three different positions - 3’, 4’ and 5’, forming seven different 




Phosphoinositides (PIs) are integral parts of membranes in the cell. PIs localise to 
different cellular membranes and are enriched in specific organelles. Their localisation 
and production depends on localisation and activity of their synthesising enzymes [2]. 
PIs are important second messengers in many signaling pathways. They are involved 
in cytoskeletal dynamics, cell movement, vesicle formation and intracellular trafficking. 
PIs also play a role in modulation of ion channels and transporters, endocytosis and 
exocytosis, and cell proliferation (reviewed in [1-3]).  
 
1.1. Nuclear metabolism of phosphoinositides 
 
Apart from the cytoplasm, phosphoinositides (PIs) also localise to the cell nucleus. 
Nuclear metabolism of PIs was reported more than three decades ago. It was shown 
that isolated nuclear envelopes from rat liver were able to incorporate radioactively 
labelled phosphorus from adenosine triphosphate (ATP). The products of this 
incorporation were phosphatidic acid (PA), phosphatidylinositol 4-phospahe (PI(4)P) 
and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) [4]. A later study showed that 
even the isolated nuclei without membranes can incorporate radioactively labelled 
phosphates into PA, PI(4)P and PI(4,5)P2. Moreover, the amount of detected 
PI(4,5)P2 was much higher in differentiated cells [5]. These data prove that there are 
phosphoinositide kinase activities within the cell nucleus and the presence of a certain 
nuclear PIs metabolism which is independent from the one in the cytoplasm. 
Following paragraphs summarise the PI-synthesising enzymes which were found 
to be present in the nucleus (Figure 2). 
Several kinases including class II phosphatidylinositol 3-kinases PI3KC2α and 
PI3KC2β, which phosphorylate phosphatidylinositol (PI) or PI(4)P to form PI(3)P or 
PI(3,4)P2, were observed in the cell nucleus [6, 7]. Two phosphatidylinositol 4-kinases 
localise to the nucleus, PI4Kα and PI4Kβ phosphorylate PI to form PI(4)P [8-10]. 
Nuclear PI(4,5)P2 can be formed by phosphorylation of PI(5)P by type II 
phosphatidylinositol 5-phosphate 4-kinases PIP4KIIα, PIP4KIIβ and PIP4KIIγ [11-14] 
or phosphorylation of PI(4)P by type I phosphatidylinositol 4-phosphate 5-kinases 
PIP5KIα and PIP5KIγ_i4 [15-17]. Kinases PIP5KIα and PIP5KIγ_i4 can also produce 
PI(3,4,5)P3 from PI(3,4)P2. Nuclear PI(3,4,5)P3 can also be produced by 
phosphorylating PI(4,5)P2 with class I phosphatidylinositol 3-kinases PI3Kβ and PI3Kγ 
[18-20], or with inositol multiphosphate kinase (IPMK) [21, 22]. 
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Four phosphatases including phosphatase and tensin homolog (PTEN); [23-25], 
Src homology 2 domain-containing inositol 5-phoshpatases 1 and 2 (SHIP-1, SHIP-2); 
[26-28], and type I PI(4,5)P2 4-phosphatase localise to the cell nucleus [29]. Although 
PTEN can dephosphorylate PI(3,4)P2 and PI(3,4,5)P3 at 3’ position of the inositol ring, 
it was shown to preferentially dephosphorylate PI(3,4)P2 in the nucleus [30]. Type I 
PI(4,5)P2 4-phosphatase generates PI(5)P from PI(4,5)P2 [29]. Nuclear SHIP-1 and 
SHIP-2 can produce PI(4)P and PI(3,4)P2 by dephosphorylating PI(4,5)P2 and 
PI(3,4,5)P3 at 5’ position of the inositol ring [26-28]. Phosphorylated SHIP-2 
preferentially dephosphorylates PI(4,5)P2 to form PI(4)P in the nucleus [27]. 
Beside phosphoinositide kinases and phosphatases, several isoforms of 
phospholipase C (PLC) localise to the cell nucleus. In particular, PLCβ1-β4, PLCγ1, 
PLCδ1, PLCδ4 and PLCζ isoforms were found to be present in the cell nucleus [31-
37]. PLC produces second messengers inositol 1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG) by cleaving PI(4,5)P2 [38]. 
 
Figure 2: Metabolism of nuclear phosphoinositides (PIs). Enzymes participating in 
nuclear metabolism of PIs are depicted: PIs kinases (black), PIs phosphatases (green) and 
phospholipases (blue). Pathways catalysed by enzymes which were confirmed to localise to 
the nucleus are depicted by black arrows and possible pathways catalysed by yet unknown 
enzymes are shown by dashed grey arrows. 
14 
 
1.2. Function of phosphoinositides in the nucleus 
  
Only 4% of the lipid content is made by phosphoinositides (PIs) in rat liver nuclei 
[39]. However, PIs are implicated in essential nuclear processes, such as DNA 
transcription, pre-rRNA and pre-mRNA processing, cell differentiation, DNA damage 
response, or apoptosis. The involvement of PIs in these processes is described in 
following chapters. 
 
1.2.1. RNA polymerase II dependent transcription 
 
Nuclear PIs play a role in DNA transcription by interaction with RNA polymerase 
II and transcription factors or at the epigenetic level by interaction with histone H1 or 
chromatin modifying proteins. 
PIs are involved in RNA polymerase II transcription by interaction with 
transcriptional activator steroidogenic factor 1 (SF-1); [40]. SF-1 is involved in the 
control of production of steroid hormones and a development of gonads and adrenal 
glands [41]. Fatty acyl chains of PIs are hidden in SF-1’s hydrophobic pocket and 
inositol head is accessible for modifications. PI(4,5)P2 binds SF-1 and is 
phosphorylated to PI(3,4,5)P3 by inositol polyphosphate multikinase (IPMK). 
PI(3,4,5)P3 bound to SF-1 is then dephosphorylated by phosphatase and tensin 
homolog (PTEN) to PI(4,5)P2. Knock-down of IMPK or overexpression of PTEN, as 
well as the disruption of SF-1 interaction with PIs, leads to the reduction of transcription 
by SF-1. The exact mechanism of action of PIs on SF-1 is not known, PI(3,4,5)P3 
production from PI(4,5)P2 bound to SF-1 enhances its transcriptional activity, most 
likely by recruiting other nuclear coactivator proteins [40, 42].  
PI(4,5)P2 was also shown to interact with RNA polymerase II. In fluorescence 
microscopy, PI(4,5)P2 co-localises with the largest subunit of RNA polymerase II 
phosphorylated in its C-terminal domain. Phosphorylated RNA polymerase II, but not 
unphosphorylated RNA polymerase II, also co-immunoprecipitates with PI(4,5)P2. 
These data suggest that PI(4,5)P2 might be involved in RNA polymerase II-mediated 





1.2.1.1. Epigenetic regulation of RNA polymerase II transcription 
 
PI(4,5)P2 is involved in the regulation of RNA polymerase II transcription through 
the specific interaction with histone H1. PI(4,5)P2 binds to the H1 C-terminal part. H1 
acts as a transcriptional repressor and its interaction with PI(4,5)P2 reverses H1’s 
inhibitory effect on transcription by RNA polymerase II. Protein kinase C 
phosphorylates histone H1 which causes the disruption of H1-PI(4,5)P2 interaction 
and then transcriptional repression [44]. 
Another way in which PI(4,5)P2 regulates the gene expression is through the 
interaction with BAF chromatin remodelling complex. BAF directly interacts with 
PI(4,5)P2 in micelles and liposomes [45]. PI(4,5)P2 mediates the interaction of BAF 
complex with actin subunit within the complex. PI(4,5)P2 enhances the interaction of 
BAF complex and chromatin during lymphocyte activation [46]. 
PI(4,5)P2 is involved in transcriptional repression through the interaction with a 
transcriptional corepressor - brain acid soluble protein 1 (BASP1). PI(4,5)P2 interacts 
with myristoylated BASP1 and they are recruited to the promoter of target genes of 
Wilms’s tumor 1 (WT1) transcriptional regulator. The interaction of PI(4,5)P2 and 
BASP1 is required for the recruitment of histone deacetylase 1 (HDAC1) to the 
promoter regions which causes a reduction in histone acetylation and then 
transcriptional repression [47].  
PI(5)P is involved in gene transcriptional regulation during myoblast differentiation. 
It interacts with TATA box binding protein (TBP)-associated factor 3 (TAF3) through 
its polybasic region (PBR) within plant homeodomain (PHD) finger. TAF3 is a 
component of RNA polymerase II pre-initiation complex [48]. Its PHD finger maintains 
the interaction with H3K4me3, a mark of active transcription. Changes in levels of 
PI(5)P, mediated by PIP4KIIβ, influence the affinity of TAF3 to H3K4me3 and thus 
gene expression of myogenic genes during myoblast differentiation [49]; (Figure 3). 
PI(5)P is also bound by PBR of ubiquitin-like PHD and really interesting new gene 
(RING) finger domain-containing protein 1 (UHRF1) and influences its function. 
UHRF1 plays a key role in targeting DNA methyltransferase 1 to replication forks in 
order to preserve the DNA methylation pattern. UHRF1 has various domains of which 
the PHD and the tandem tudor domain (TTD) are responsible for recognising histone 
modifications. When PI(5)P is bound to PBR, UHRF1-TTD domain recognises 
H3K9me3. When PI(5)P is not present, PBR blocks the interaction of TTD and 
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H3K9me3 and UHRF1-PHD domain recognises unmodified H3. These binding 
properties are facilitated by conformational changes of UHRF1 protein caused by 
binding of PI(5)P to PBR region. PI(5)P acts as a allosteric modulator of UHRF1 
activity [50].  
In plants, the activity of (Arabidopsis homolog of trithorax) ATX1 is negatively 
regulated by PI(5)P. ATX1 methylates lysines 4 on histones H3. PI(5)P interacts with 
PHD finger domain within ATX1 protein [51]. Elevated levels of PI(5)P cause a 
translocation of ATX1 from the nucleus to the cytoplasm and a reduction of H3K4me3 
levels and thus transcription inhibition [52]. 
 
 
Figure 3: PI(5)P changes the gene expression through the interaction with TAF3. 
PI(5)P interacts with PHD domain of TAF3, which is responsible for binding to H3K4me3. 
PIP4KIIβ-mediated changes of PI(5)P levels, influence the affinity of TAF3 to H3K4me3 and 
thus expression of target genes. TAF3 - TATA box binding protein-associated factor 3, PHD - 
plant homeodomain finger. Taken and modified from Stijf-Bultsma et al., 2015 [49]. 
 
1.2.2. RNA polymerase I dependent transcription 
 
PI(4,5)P2 is required for transcription by RNA polymerase I (RNA pol I). PI(4,5)P2 
depletion from the nuclear extract causes significant reduction in the level of RNA 
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polymerase I transcription in vitro. Addition of PI(4,5)P2 restores the level of RNA pol 
I transcription. PI(4,5)P2 is a component of RNA pol I machinery; it interacts with RNA 
pol I and a transcription factor UBF (upstream binding factor). PI(4,5)P2 binds UBF 
directly which causes conformational changes and this interaction enhances the 
binding of UBF to rDNA. These observations suggest the involvement of PI(4,5)P2 in 
forming the transcription initiation complex and RNA Pol I transcriptional activation 
[53].  
PI(4,5)P2 also regulates RNA polymerase I at the epigenetic level by interaction 
with histone lysine demethylase PHD finger protein 8 (PHF8). PI(4,5)P2 binds directly 
to K/R-rich motif within PHF8 protein sequence and influences its demethylase 
function. PHF8 demethylates H3K9me1/2 at rDNA promoter and thus activates rDNA 
transcription [54]. The disruption of the PI(4,5)P2-PHF8 interaction led to the increased 
pre-rRNA transcription. PI(4,5)P2 maintains the level of rDNA transcription by 
inhibiting the H3K9me2 demethylase activity of PHF8 [55]. 
 
1.2.3. RNA processing 
 
Phosphoinositides play a role in pre-rRNA and pre-mRNA processing. PI(4,5)P2 
localises to interchromatin granular clusters (IGCs) which contain proteins involved in 
DNA transcription and pre-mRNA processing. In fluorescence microscopy, PI(4,5)P2 
co-localises with a splicing factor SC-35, which localises to IGCs. These data suggest 
that PI(4,5)P2 might be involved in pre-mRNA splicing. Immunodepletion of PI(4,5)P2 
from nuclear extract inhibited the splicing reaction in vitro. Addition of PI(4,5)P2 and 
its binding partners into the splicing reaction can partially restore the splicing activity. 
However, the direct role of PI(4,5)P2 in splicing is not known [43]. 
PI(4,5)P2 also plays a role in polyadenylation of mRNA. It stimulates the activity 
of nuclear speckle targeted PIP5KIα regulated-poly(A) polymerase (Star-PAP), which 
results in longer poly(A) tails. Other phosphoinositides do not have the same effect. 
As a response to oxidative stress, Star-PAP and PIP5KIα complex is formed where 
PI(4,5)P2, produced by PIP5KIα, affects the processivity of Star-PAP and 
polyadenylation of its targeted mRNAs [16]. 
Moreover, PIs are involved in the nuclear mRNA export. PI(4,5)P2 and PI(3,4,5)P3 
directly interact with nuclear export factor Aly through its N-terminus rich in lysines and 
arginines [56]. Aly is a component of transcription-export (TREX) complex which is 
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recruited to spliced mRNA in a transcription-independent manner [57]. 
Phosphorylation of Aly by Akt kinase is important for binding to PI(3,4,5)P3. Inhibition 
of kinase activity decreased the Aly-PI(3,4,5)P3 binding. The disruption of the 
interaction between PI(3,4,5)P3 and Aly leads to attenuated mRNA export and cell 
proliferation [56]. Moreover, Wickramasinghe et al. showed the phosphorylation of 
PI(4,5)P2 to PI(3,4,5)P3 by IPMK regulates the selection of gene transcripts involved 
in DNA repair process (e.g. RAD51 recombinase) for the nuclear export (Figure 4). 
IPMK depletion causes the accumulation of mRNAs and PI(4,5)P2 in nuclear 
speckles. The recognition of target mRNAs by Aly is decreased after IPMK depletion, 
but addition of PI(3,4,5)P3 partially restores the binding of Aly to mRNAs [58]. 
PI(4,5)P2 is also involved in early stages of pre-rRNA processing in the nucleolus. 
PI(4,5)P2 interacts with protein fibrillarin, which plays a role in modification and 
processing of pre-rRNA during ribosomal assembly [59]. The direct interaction of 
PI(4,5)P2 and fibrillarin causes its conformational changes and modulates its binding 





Figure 4: Regulation of nuclear mRNA export by PIs. The phosphorylation of PIP2 to 
PIP3 by IPMK regulates the selection of gene transcripts involved in DNA repair process (e.g. 
RAD51 recombinase) for the nuclear export. PIP2 - phosphatidylinositol 4,5-bisphosphate, 
PIP3 - phosphatidylinositol 3,4,5-trisphosphate, IPMK - inositol polyphosphate multikinase, 
Nups - nucleoporins, HR - homologous recombination. Taken from Wickramasinghe et al., 
2013 [58]. 
 
1.2.4. DNA damage response 
 
Phosphoinositides are also involved in response to the DNA damage. The DNA 
damage induced by irradiation or chemical modification increases levels of PIs in the 
cell nucleus. PIs are rapidly accumulated at DNA damage sites. PI(4,5)P2 and 
PI(3,4,5)P3 are important for the recruitment of Ataxia telangiectasia and Rad3-related 
protein (ATR) to DNA damage sites [60]. ATR is a serine/threonine kinase which 
phosphorylates a number of substrates as a response to the DNA damage, which 
causes the inhibition of DNA replication and the stimulation of DNA repair process 
[61]. ATR is most likely recruited to the DNA damage sites due to an actin 
polymerisation mediated by PIs [60]. 
PI(5)P also plays an important role in the DNA damage response. It interacts with 
inhibitor of growth family member 2 protein (ING2) through its PHD finger domain, 
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which can then bind to H3K4me3 at promoter regions of DNA damage-responsive 
genes. ING2 is a part of a chromatin modification complex composed of HDAC1 and 
transcriptional corepressor Sin3A [62]. The DNA damage associated gene repression 
is impaired when ING2-PI(5)P interaction is obstructed [63]. The levels of PI(5)P are 
increased upon UV irradiation. This is due to the inhibition of PIP4KIIβ, which 
generates PI(4,5)P2 from PI(5)P. PIP4KIIβ is phosphorylated by p38 kinase upon UV 
irradiation and its activity is inhibited [64]. Overexpression of PIP4KIIβ leads to a 
decreased level of ING2 signal in the cell nucleus and an increased level of ING2 
signal in the cytoplasm. This reduction of PI(5)P level causes de-association of ING2 
from chromatin. Binding of PI(5)P to ING2 is important for association of ING2 with 
chromatin, and is required for p53 activation and p53-mediated apoptosis [65]. 
Similarly, the elevated PI(5)P levels can also be caused by type I PI(4,5)P2 
phosphatase, which generates PI(5)P from PI(4,5)P2. This enzyme is translocated to 
the nucleus upon DNA damage induction, the elevated PI(5)P levels stimulate the p53-






The involvement of phosphoinositides (PIs) in the cell signalling and diseases make 
them very important players in the organism. It is therefore crucial to study the basic 
processes they are involved in. PI(4)P and PI(4,5)P2 are the most abundant PIs in the 
cell. Still, we lack a knowledge about their precise localisation and function. The 
function of nuclear PI(4)P is completely unknown. Thus, we will address following 
questions: 
1. Which tools are applicable for detection of nuclear phoshoinositides? 
2. What is the distribution of phosphoinositides within the nucleus, in 
particular PI(4)P and PI(4,5)P2? 
3. What are the binding partners of PI(4)P and PI(4,5)P2 in the cell 
nucleus? 
4. How is PI(4,5)P2 involved in DNA transcription? 
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4.1. Visualisation tools for nuclear phosphoinositides 
 
More than 30 years ago, phosphoinositides (PIs) were found present in the cell 
nucleus [4, 5]. Until now, there have been observed numerous functions of PIs in 
nuclear processes, such as epigenetic regulation of DNA transcription, pre-mRNA 
processing and DNA damage (reviewed in [67, 68]). However, we still lack knowledge 
about their detail localisation, metabolism and function in the cell nucleus. For the 
purpose of studying their function, reliable tools for in vitro and in vivo visualisation of 
PIs in the cell nucleus are required. 
We tested commercially available antibodies and phosphoinositde-binding 
domains as tools for their visualisation. By overexpression of PIs-binding domains, we 
were not able to detect nuclear pools of PIs. Overexpressed PLCδ-PH, Tubby, Grp1-
PH, Akt-PH, OSH1-PH failed to recognise nuclear PI(4,5)P2, PI(3,4)P2, PI(3,4,5)P3 
and PI(4)P [69]. Mutant domains resembled the signal of wild-type domains. This 
observation might be a consequence of overexpression of GFP-tagged domains, 
which are enriched unspecifically in the nucleus after the overexpression due to their 
ability to diffuse into the nucleus because of their size [70]. Only overexpressed EEA1-
FYVE domain recognised PI(3)P signal in the nucleolus, which was lost in the mutant 
domain [69]. These data correspond with previous observation of PI(3)P enriched in 
dense fibrillar component of nucleoli of human and baby hamster kidney fibroblasts. 
PI(3)P was detected by double FYVE domain of the receptor tyrosine kinase substrate 
Hrs [71]. The function of PI(3)P in the nucleus is unknown. 
The overexpression of PIs-binding domains failed to localise PIs in the nucleus, 
therefore we purified PLCδ-PH, Tubby and OSH1-PH domains tagged with eGFP and 
incubated them with fixed and permeabilised cells as analogous to antibodies. Purified 
PLCδ-PH and Tubby domains detected PI(4,5)P2 in nucleoli, nuclear speckles and 
nucleoplasm. The same pattern was also observed by anti-PI(4,5)P2 antibody. Beside 
PI(4,5)P2, the antibody also recognises PI(3,4,5)P3 on protein-lipid overlay assay. 
However, when PI(3,4,5)P3 was pre-incubated with the antibody, PI(4,5)P2 signal 
decreased only partially, whereas the pre-incubation with PI(4,5)P2 abrogated the 
PI(4,5)P2 signal fully [69]. The levels of PI(3,4,5)P3 in the cell are about twenty times 
lower than the levels of PI(4,5)P2 [70], therefore we believe that the anti-PI(4,5)P2 
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antibody recognises the nuclear pool of PI(4,5)P2. Purified OSH1-PH domain detected 
PI(4)P in nuclear speckles and nucleoplasm. A similar pattern was also observed by 
anti-PI(4)P antibody. The antibody specifically recognises PI(4)P on protein-lipid 
overlay assay and it was also blocked only by PI(4)P in antibody blocking assay [69].  
In conclusion, anti-PI(4,5)P2 and  purified GFP-tagged PLCδ-PH domain are 
suitable for detection of nuclear PI(4,5)P2 and anti-PI(4)P and purified GFP-tagged 
OSH1-PH domain are suitable for detection of nuclear PI(4)P. Using appropriate 
controls, these tools are applicable for visualisation of phosphoinositides in the cell 
nucleus. 
 
4.2. PI(4)P and PI(4,5)P2 localisation and function within nuclear 
sub-compartments is different 
 
PI(4)P and PI(4,5)P2 are the two most abundant phosphoinositides in the cell [2], 
therefore we focused on studying their localisation by super-resolution and electron 
microscopy with tested antibodies and PI-binding domains. PI(4)P and PI(4,5)P2 are 
localised to the same nuclear sub-compartments, however their distribution within the 
sub-compartments is different.  
We showed that PI(4)P specifically localises to nuclear lamina, nucleolus, nuclear 
speckles and small nucleoplasmic foci [72]. PI(4,5)P2 localises to nucleolus, nuclear 
speckles and small nucleoplasmic foci as well [73]. Small portions of PI(4)P and 
PI(4,5)P2 can be detected within nucleoli. Through the use of transmission electron 
microscopy, we detected PI(4)P predominantly in dense fibrillar component (DFC) and 
smaller portion also localises to a granular component (GC) of nucleoli [72]. On the 
contrary, nucleolar PI(4,5)P2 signal is denser in fibrillar centre (FC) and DFC [74]. The 
nucleoli are known sites of ribosome biogenesis. Proteins involved in rDNA 
transcription are stored in FCs which are surrounded by DFCs. Transcription of rDNA 
occurs at the border of FC/DFC and early rRNA processing also occurs in DFC, while 
components involved in later rRNA processing are localised to GC [75, 76]. It was 
shown that PI(4,5)P2 associates with RNA polymerase I (RNA pol I) transcription 
machinery and it is important for promoting the transcription by RNA pol I [53]. Our 
data propose that PI(4,5)P2 might be dephosphorylated to PI(4)P during the 
transcription of rDNA or during the early stages of rRNA processing happening in DFC. 
PI(4)P might also play a role during the later stages of ribosomal assembly due to its 
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localisation to GC. PI(4)P might also be generated in the nucleolus from 
phosphatidylinositol by phosphatidylinositol 4-kinase PI4Kα which was shown to 
localise to the nucleolus [9, 10]. 
Moreover, PI(4)P and PI(4,5)P2 localise to nuclear speckles. PI(4,5)P2 signal is 
denser in nuclear speckles than the PI(4)P signal. Close to 16 % of total nuclear PI(4)P 
localises to nuclear speckles, whereas nearly 70 % of total nuclear PI(4,5)P2 localises 
to nuclear speckles [72, 73]. PI(4)P localises more at the edges of nuclear speckles, 
where the active transcription of several genes occur [77-79]. PI(4,5)P2 localises 
inside of speckles rather than at their edges. In addition, enzymes which synthesise 
PI(4)P and PI(4,5)P2 also localise to the nuclear speckles. Particularly, 
phosphatidylinositol 4-kinase PI4Kβ which generates PI(4)P from PI [80], 
phosphatidylinositol 4-phospate 5-kinases PIP5Kiα and PIP5KIγ_i4 [15-17], which 
phosphorylate PI(4)P to PI(4,5)P2 and SHIP-2 phosphatase which dephosphorylates 
PI(4,5)P2 to PI(4)P [27]. These data clearly suggest that there is an active 
interconversion of PI(4)P and PI(4,5)P2 happening in nuclear speckles, which might 
be coupled with regulation of the activity of certain proteins by phosphorylation and 
dephosphorylation of bound PI(4)P/PI(4,5)P2. Furthermore, phosphatidylinositol 3-
kinase PI3KC2α is present in the nuclear speckles which indicates the presence of 
PI(3)P, PI(3,4)P2 and PI(3,4,5)P3 in nuclear speckles as well [6]. Nuclear speckles 
can serve as a place for the metabolism and the storage of nuclear PIs. Additionally, 
PIs might be involved in transcription and splicing via interaction with nuclear speckle 
associated proteins. 
During cell division, PI(4)P and PI(4,5)P2 are dispersed in the cytoplasm [72, 74]. 
Moreover, PI(4,5)P2 was shown to localise to nucleolar organising regions (NORs) 
together with UBF and RNA polymerase I [74], and also to mitotic interchromatin 
granules (MIGs) together with nuclear speckle associated proteins [43].On the other 
hand, PI(4)P is not localised in NORs, MIGs or any other structures which supports 
their functional difference in the cell nucleus [72]. 
Furthermore, we found that 28 % of overall nuclear PI(4,5)P2 localises to 
nucleoplasm and it forms foci which are 40-100 nm in diameter, we called them nuclear 
lipid islets (NLIs). They are composed of lipids and are surrounded by proteins, DNA 
and RNA. DNA is not an integral part of NLIs, because NLIs’ staining was resistant to 
DNase treatment. On the other hand, NLIs’ staining was lost after RNase treatment, 
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which shows that RNA is the integral part of NLIs. Indeed, we showed that 
approximately 70 % of NLIs co-localised with RNA located on their surface [73].  
By immunofluorescence and immunoprecipitation experiments, we showed that 
NLIs are associated with nascent transcripts, RNA polymerase II (RNA pol II) and 
general transcription factors. The reduction of PI(4,5)P2 level led to decreased level 
of RNA pol II transcription, which suggests that RNA pol II transcription requires intact 
NLIs [73]. We propose that NLIs provide a structural platform promoting the formation 
of RNA pol II transcription complexes. 
Other lipid structures, nuclear lipid droplets (nLDs), were previously identified in 
the nucleus. They have hydrophobic core consist of triacyglycerols and cholesterol, 
and hydrophilic surface consist of polar lipids and proteins [81]. Although nLDs and 
NLIs are organised similarly, nLDs are approximately ten times bigger than NLIs and 
are usually connected with extended inner nuclear membrane [82]. 
As PI(4,5)P2 is an essential component of NLIs in the nucleoplasm, we tested 
whether PI(4)P is the component of NLIs as well. By electron microscopy, we 
visualised both phosphoinositides and we did not observe the significant co-
localisation of PI(4)P and PI(4,5)P2 in NLIs. In addition, the foci formed by PI(4)P are 
much smaller than the foci formed by PI(4,5)P2 and they are apparently part of 
different nuclear protein-lipid complexes [72]. 
All our observed data point to distinct nuclear functions of PI(4)P and PI(4,5)P2. 
PI(4)P has a unique role in regulation of nuclear processes, it is not just a precursor 
of PI(4,5)P2. 
 
4.3. Binding partners of PI(4)P and PI(4,5)P2 and their function 
 
To elucidate the role of PI(4)P in nuclear processes, we identified its potential 
nuclear protein binding partners by immunoprecipitation with the anti-PI(4)P antibody 
followed by mass spectrometry analysis of nuclear extracts. As PI(4,5)P2 binding 
partners are better-known, we included anti-PI(4,5)P2 immunoprecipitation for MS 
analysis as well to compare PI(4)P and PI(4,5)P2 protein interactors. 
Nearly 100 nuclear proteins were identified, which are involved in pre-mRNA and 
pre-rRNA processing, transcriptional regulation, transport, ribosomal assembly, DNA 
replication and repair. It corresponds with observed localisation of PI(4)P in the cell 
nucleus. Among the detected nuclear interactors, there were twelve proteins enriched 
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only in PI(4)P fraction, compared to control and PI(4,5)P2 fraction (Table S1, blue); 
[72]. The proteins are determined as fundamental components of various nuclear 
processes, like DNA replication, transcription and pre-mRNA splicing [83]. Although, 
these 12 proteins were found only in PI(4)P fraction, their interaction with PI(4)P needs 
to be verified by additional approaches. The majority of the identified interactors were 
found in both PI(4)P and PI(4,5)P2 immunoprecipitates [72]. Considering that PI(4)P 
is a precursor for PI(4,5)P2, or vice versa [67], they can have similar interaction 
partners. It was shown that phosphorylation of PIs, directly bound to proteins, can 
change the protein conformation and thus binding affinities of the proteins to their 
binding partners in a functional complex [42, 58]. 
The interaction of identified heterogeneous nuclear ribonucleoprotein U (hnRNP 
U), nuclear RNA export factor 1 (NXF1) and nuclear mitotic apparatus protein (NuMa) 
with PI(4)P and PI(4,5)P2 was verified by antibodies and PI-coated beads on Western 
blot [72]. The proteins showed different binding patterns to both PIs which could be an 
outcome of different antibodies’ affinity to their corresponding epitopes and PI-coated 
beads to their baits. NuMa was previously described as a phosphoinositide-interacting 
protein [84]. HnRNP U is involved in initiation of transcription by RNA polymerase II. 
Together with actin, hnRNP U interacts with phosphorylated C-terminal domain of 
RNA polymerase II and decreased levels of hnRNP U abolished incorporation of 
BrUTP into nascent RNA [85]. We showed that the reduction of PI(4,5)P2 level led to 
decreased level of RNA polymerase II transcription. Potentially, PI(4)P, PI(4,5)P2 and 
hnRNP U might cooperate in the initiation of transcription. NXF1 plays a role in the 
mRNA export from the cell nucleus as a part of TREX complex [86]. Another 
component of TREX complex, Aly, was found to interact with PIs. The interaction of 
Aly and PI(3,4,5)P3 is crucial for functional mRNA export [56]. These results indicate 
that PIs might be essential parts of mRNA transport complexes. 
We also showed that nuclear myosin 1 (NM1) localises to the NLIs’ periphery. 
NM1 interacts with PI(4,5)P2 directly through its pleckstrin homology (PH) domain [73]. 
NM1 is involved in initiation of RNA polymerase II transcription [87]. Knock-down of 
NM1 decreased the level of RNA pol II transcription. Subsequent overexpression of 
NM1 rescued the RNA pol II transcription level, however the overexpression of NM1 
mutated in PI(4,5)P2-binding site failed to rescue the transcription [73]. These data 
suggest that PI(4,5)P2-NM1 interaction is required for RNA pol II transcription. NM1 
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recruits chromatin remodelling complexes to gene promoters [88], and PI(4,5)P2 
interaction with NM1 might be crucial for this regulation. 
Lysine-specific histone demethylase 1 (LSD1) was also identified as PI-interacting 
protein [89]. We showed that LSD1 interacted with multiple PIs directly, but the 
strongest interaction was with PI(4)P. LSD1 demethylates H3K4me2 and H3K4me1 
histone active marks and thus represses transcription [90]. We studied how PIs can 
influence LSD1 function. The binding of PI(4)P to LSD1 inhibited its activity, but on the 
other hand, the binding of PI(4,5)P2 to LSD1 stimulated its activity in vitro (Kalasova, 
manuscript). Phosphorylation of PI(4)P or dephosphorylation of PI(4,5)P2 might also 
have a quick regulatory effect on LSD1 function in vivo. It was shown that 
phosphorylation of PIs can cause conformational changes of their binding partners 
and thus the binding to their protein interactors and function [53]. LSD1 does not have 
any DNA- or histone-binding domains, therefore it is dependent on the interaction with 
other proteins within chromatin modifying complexes and PIs might regulate these 
interactions and thus the function of LSD1 in gene expression.  
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5. Summary and conclusions 
 
5.1. PI-binding domains are suitable for detection of PIs in the cell nucleus 
Purified GFP-tagged PLCδ-PH and Tubby domains detect PI(4,5)P2 in nucleoli, 
nucleoplasm and nuclear speckles. Using purified GFP-tagged OSH1-PH, PI(4)P was 
detected in nucleoplasm and nuclear speckles for the first time. 
5.2. PI(4)P localises to the cell nucleus 
PI(4)P is present in the nuclear lamina, the nuclear speckles, the nucleoli and it forms 
small foci in the nucleoplasm. The foci are 50 nm in size and are enriched on 
chromatin. A small portion of PI(4)P localises to the nucleoli, it is predominantly 
enriched in DFC and less enriched in GC. Almost 16 % of nuclear PI(4)P is present in 
the nuclear speckles and the rest localises to the nucleoplasm. 
5.3. PI(4)P is in complex with nuclear proteins involved in gene expression 
Mass spectrometry analysis of immunoprecipitated PI(4)P lipid-protein complexes 
revealed almost 100 nuclear proteins enriched in the PI(4)P fraction. The proteins 
participate in essential nuclear processes such as pre-mRNA processing, transcription 
or nuclear transport indicating the role of PI(4)P as an important player in the cell 
nucleus. 
5.4. Localisation of PI(4)P is different than the localisation of PI(4,5)P2 
Both PI(4)P and PI(4,5)P2 localise to the nuclear speckles, the nucleoli and the 
nucleoplasm, but their distribution within the sub-compartments is different. In the 
nucleolus, PI(4,5)P2 is predominantly enriched in FC and DFC and PI(4)P is 
predominantly enriched in DFC and less in GC. In the nucleoplasm, PI(4)P forms 
smaller foci than PI(4,5)P2 and is not detected in nuclear lipid islets. 
5.5. Nuclear lipid islets are structural platforms for formation of RNA polymerase 
II transcription complexes 
Nuclear lipid islets (NLIs) are nucleoplasmic structures 40-100 nm in size. Their core 
is rich in lipids and it is surrounded with proteins, RNA and DNA. The NLIs’ periphery 
is associated with RNA polymerase II transcription machinery. The levels of active 
RNA polymerase II transcription are dependent on the levels of PI(4,5)P2. NLIs 
30 
 
provide a structural platform promoting the formation of RNA pol II transcription 
complexes. 
5.6. PI(4)P and PI(4,5)P2 regulate the function of LSD1 
Histone demethylase LSD1 demethylates H3K4me1/2 histone marks and binds 
phosphoinositides directly. In vitro, when PI(4)P is bound to LSD1, its activity is 
inhibited. On the other hand, when PI(4,5)P2 is bound to LSD1, its demethylase 




6. Future prospects 
Our data indicate that PI(4)P and PI(4,5)P2 are important for DNA transcription. 
PI(4,5)P2 regulates transcription by interacting with RNA polymerase II and general 
transcription factors. Moreover, together with PI(4)P, they regulate transcription also 
at the epigenetic level by regulating the activity of histone demethylase. Accordingly, 
we would like to address the following interesting questions: 
6.1. How is LSD1 regulated by PIs? 
Phosphoinositides regulate activity of proteins as their allosteric modulators by 
changing their conformation or as signalling molecules by recruiting their interactors 
to the protein-lipid complex. We showed that PI(4)P inhibits and PI(4,5)P2 stimulates 
the H3K4me2 demethylase activity of LSD1. However, it is uncertain how PIs regulate 
the LSD1 function. To study the mechanism of this regulation is necessary as LSD1 
is important in cancer and neurodegenerative diseases. The inhibition of LSD1 
abolishes the growth of acute myeloid leukemia cells [91], therefore it is a potential 
target for treatment of this disease. 
6.2. Do NLIs regulate global transcription or transcription of specific genes? 
NLIs are associated with nascent transcripts, RNA polymerase II and general 
transcription factors. NLIs provide a structural platform promoting the formation of RNA 
pol II transcription factories. However, it is not clear which genes are transcribed at the 
periphery of NLIs. It would be interesting to address whether particular sets of genes 
are transcribed at the NLIs’ periphery and how NLIs regulate their expression. 
6.3. What is the function of PI(4)P-hnRNP U complex? 
Nuclear PI(4)P interacts with a number of nuclear proteins involved in RNA 
processing, transcriptional regulation, nuclear transport and other. We showed that 
hnRNP U interacts with PI(4)P and PI(4,5)P2. The majority of nuclear PI(4)P localises 
to the nucleoplasm and is enriched on chromatin. It was shown that hnRNP U 
regulates chromatin compaction by oligomerisation and interaction with chromatin-
associated RNAs [92]. Therefore, it would be interesting to address how PI(4)P 
influences the function of hnRNP U and whether PI(4)P-hnRNP U interaction is 




6.4. What is a turnover of PIs during the cell cycle? 
Most of the PIs localise to the cell nucleus as well as their metabolising enzymes. In 
interphase, the majority of PI(4)P and PI(4,5)P2 localise to nucleoplasm and nuclear 
speckles, and during mitosis, PI(4)P and PI(4,5)P2 undergo a redistribution in the cell 
[43, 74]. However, it is not known whether the levels of PIs also change during the cell 
cycle. Therefore, the analysis of the levels of all PIs during all stages of the cell cycle 
is needed. It would be also interesting to analyse portions of individual PIs in nuclear 
membrane, nuclear speckles, nucleoli and nucleoplasm by nuclear fractionation 
followed by lipid mass spectrometry, which might point towards their function in the 
cell nucleus. For future studies, it is crucial to detect and manipulate the levels of PIs 
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